Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New genetic clues could explain unexplained miscarriages

NCT ID NCT05658445

Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to find new reasons why some women have repeated miscarriages with no known cause. Researchers looked at specific genetic markers (microRNA 410 and BIRC7) in 86 women aged 20-30 who had two or three miscarriages. The goal was to better understand the disease, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

86 people

The number who actually took part.

Started

Jan 2023

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Female without cancer or chronic illness that exposed to 2 or 3 consecutive or discontinues abortion

Ages

20 to 30 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: maternal age is between 20 to 30 years and Gestational age before abortion less than 24 weeks. Female with unexplained two or three consecutive or discontinuous miscarriages with the same sexual partner Exclusion Criteria: 1. Female with one miscarriage 2. Female with explained causes of miscarriage 3. Female with cancer 4. Female with chronic illness. 5. Pregnant women above 30

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abortion, habitual are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

habitual spontaneous abortion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abortion, habitual

Contacts and locations

Locations

  • Medical Bochemistry Department

    Asyut, Assuit, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.